Friday, January 30, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Calix Surpasses Billion-Dollar Revenue Milestone Amid Cautious Guidance

Robert Sasse by Robert Sasse
January 30, 2026
in Analysis, Earnings, Tech & Software, Telecommunications
0
Calix Stock
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

For the first time in its corporate history, Calix has exceeded one billion dollars in annual revenue. The company’s full-year 2025 results showcase record-breaking performance, yet investor sentiment has been tempered by a conservative forecast for the immediate quarter ahead. This divergence between a strong operational track record and near-term caution is shaping the market’s reaction.

Financial Performance and Capital Allocation

The company’s fourth quarter saw revenue advance by 32% year-over-year to $272.4 million. On an adjusted basis, earnings per share came in at $0.39, meeting consensus estimates. A key highlight was the eighth consecutive quarterly improvement in non-GAAP gross margin, which reached a new peak of 58%.

Demonstrating confidence in its long-term value, Calix’s board has authorized a new $125 million share repurchase program. This follows the repurchase of $17 million worth of its own shares during Q4. The company concluded the period with a robust financial position, holding cash, cash equivalents, and investments totaling $388 million.

Strategic Execution and AI Roadmap

Operationally, management is progressing with its customer migration initiative. More than 300 customers transitioned to the company’s third-generation platform in December alone. This technological foundation is considered pivotal for integrating artificial intelligence capabilities, which Calix is enhancing through a global partnership with Google Cloud. The majority of the remaining customer migrations are targeted for completion by mid-2026.

Should investors sell immediately? Or is it worth buying Calix?

The strategic shift toward cloud services and platform solutions is reflected in the balance sheet. Remaining Performance Obligations (RPO) climbed to a record $385 million at year-end, representing an 18% increase from the prior year.

Conservative Outlook Overshadows Records

Looking to the first quarter of 2026, Calix provided revenue guidance in a range of $275 million to $281 million. The midpoint of this range implies sequential growth of approximately 2% over the previous quarter. This projection was viewed by market observers as conservative, falling short of more aggressive analyst estimates and contributing to recent pressure on the share price.

Investor attention now turns to the upcoming Investor Day scheduled for February 24th at the New York Stock Exchange. Management is expected to detail plans for capitalizing on the U.S. government’s BEAD broadband expansion funding program. Calix estimates the additional market opportunity from BEAD to be between $1.0 billion and $1.5 billion.

Key Financial Highlights (2025):
* Annual Revenue: Surpassed $1.0 billion (Milestone achieved)
* Q4 Revenue: $272.4 million (32% year-over-year growth)
* Non-GAAP Gross Margin: 58% (Eighth consecutive quarterly increase)
* Q4 Free Cash Flow: $40 million
* Share Repurchases: New $125 million program authorized

Ad

Calix Stock: Buy or Sell?! New Calix Analysis from January 30 delivers the answer:

The latest Calix figures speak for themselves: Urgent action needed for Calix investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 30.

Calix: Buy or sell? Read more here...

Tags: Calix
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Host Hotels, Resorts Stock
Earnings

Host Hotels & Resorts Eyes Major Portfolio Shift with Billion-Dollar Asset Sale

January 30, 2026
Fiserv Stock
Analysis

Fiserv Faces Cybersecurity Lawsuit Ahead of Earnings Report

January 30, 2026
Evergy Stock
Dividends

Evergy Sets Date for 2025 Financial Report, Investors Eye Growth Strategy

January 30, 2026
Next Post
ServiceNow Stock

ServiceNow Shares Slide Despite Strong Quarterly Performance

IonQ Stock

The Quantum Computing Divide: A Tale of Two Investment Strategies

Protalix Biotherapeutics Stock

Protalix Biotherapeutics Approaches Pivotal Catalysts

Recommended

Tilray Stock

Tilray’s Strategic Push Faces Investor Skepticism Amid Persistent Losses

3 days ago
Schwab Stock

Charles Schwab Shares: Strong Fundamentals Meet Market Skepticism

2 months ago

Novartis Expands Oncology Portfolio through Acquisition of MorphoSys

2 years ago
Neogen Stock

Neogen Shares at Critical Juncture Amid Leadership and Technical Challenges

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Gold’s Unprecedented Surge: Investors Seek Shelter in Micro-Cost ETFs

Protalix Biotherapeutics Approaches Pivotal Catalysts

The Quantum Computing Divide: A Tale of Two Investment Strategies

ServiceNow Shares Slide Despite Strong Quarterly Performance

Calix Surpasses Billion-Dollar Revenue Milestone Amid Cautious Guidance

A Strategic Shift: Nvidia Poised to Become TSMC’s Top Revenue Driver

Trending

Host Hotels, Resorts Stock
Earnings

Host Hotels & Resorts Eyes Major Portfolio Shift with Billion-Dollar Asset Sale

by Andreas Sommer
January 30, 2026
0

Reports emerged on Wednesday indicating that Host Hotels & Resorts, a leading real estate investment trust (REIT)...

Fiserv Stock

Fiserv Faces Cybersecurity Lawsuit Ahead of Earnings Report

January 30, 2026
Evergy Stock

Evergy Sets Date for 2025 Financial Report, Investors Eye Growth Strategy

January 30, 2026
iShares® Gold Trust Micro Stock

Gold’s Unprecedented Surge: Investors Seek Shelter in Micro-Cost ETFs

January 30, 2026
Protalix Biotherapeutics Stock

Protalix Biotherapeutics Approaches Pivotal Catalysts

January 30, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Host Hotels & Resorts Eyes Major Portfolio Shift with Billion-Dollar Asset Sale
  • Fiserv Faces Cybersecurity Lawsuit Ahead of Earnings Report
  • Evergy Sets Date for 2025 Financial Report, Investors Eye Growth Strategy

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com